Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Biocure Technology Inc (CN: CURE)

 
CURE Technical Analysis
2
As on 11th Nov 2024 CURE STOCK Price closed @ 0.04 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.03 & Strong Sell for SHORT-TERM with Stoploss of 0.05 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CURESTOCK Price

Open 0.04 Change Price %
High 0.04 1 Day 0.00 0.00
Low 0.04 1 Week 0.03 300.00
Close 0.04 1 Month 0.03 300.00
Volume N/A 1 Year -0.05 -55.56
52 Week High 0.09 | 52 Week Low 0.00
 
CN Canada Most Active Stocks
BTC 0.70 169.23%
BIGG 0.22 15.79%
FNQ 0.01 %
ACDC 0.06 0.00%
RVV 0.01 %
FMAN 0.55 7.84%
TER 2.80 5.66%
GSK 0.54 20.00%
IP 0.12 -14.29%
USGD 0.16 14.29%
 
CN Canada Top Gainers Stocks
BTC 0.70 169.23%
BTC 0.70 169.23%
BTC 0.70 169.23%
BLR 0.02 100.00%
BLR 0.02 100.00%
BLR 0.02 100.00%
XCX 0.02 100.00%
MICH 0.13 62.50%
LLL 0.14 55.56%
LLL 0.14 55.56%
 
CN Canada Top Losers Stocks
GTG 0.37 -97.30%
GTG 0.37 -97.30%
MJRX 0.01 -50.00%
XBLK 0.02 -50.00%
SLZ 0.02 -50.00%
SLZ 0.02 -50.00%
SLZ 0.02 -50.00%
BAMM 0.02 -33.33%
CNTR 0.02 -33.33%
GOH 0.06 -33.33%
 
 
CURE
Daily Charts		 CURE
Intraday Charts		 Whats New @
Bazaartrend		 CURE
Free Analysis
 
CURE Important Levels Intraday
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
 
CURE Forecast November 2024
Share
4th UP Forecast0.12
3rd UP Forecast0.09
2nd UP Forecast0.08
1st UP Forecast0.06
1st DOWN Forecast0.02
2nd DOWN Forecast0
3rd DOWN Forecast-0.01
4th DOWN Forecast-0.04
 
CURE Weekly Forecast
4th UP Forecast0.16
3rd UP Forecast0.12
2nd UP Forecast0.10
1st UP Forecast0.07
1st DOWN Forecast0.01
2nd DOWN Forecast-0.02
3rd DOWN Forecast-0.04
4th DOWN Forecast-0.08
 
CURE Forecast2024
4th UP Forecast0.21
3rd UP Forecast0.16
2nd UP Forecast0.12
1st UP Forecast0.09
1st DOWN Forecast-0.01
2nd DOWN Forecast-0.04
3rd DOWN Forecast-0.08
4th DOWN Forecast-0.13
 
 
CURE Other Details
Segment EQ
Market Capital 16985482.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CURE Address
CURE
 
CURE Latest News
 
Your Comments and Response on Biocure Technology Inc
 
CURE Business Profile
Biocure Technology Inc. develops and commercializes biopharmaceutical technologies for uses in recombinant and ranibizumab. The company is developing Interferons- ß for the treatment of multiple sclerosis; Ranibizumab, a monoclonal antibody fragment for the treatment of macular degeneration, as well as to treat a type of eye problem known as macular edema; and Filgrastim to treat neutropenia, a lack of white blood cells caused by cancer, bone marrow transplant, chemotherapy, or by other conditions. It is also developing CAR T Cell Therapy that identifies and destroys cancer cells; a foot and mouth disease vaccine; and hair growth products. Biocure Technology Inc. was founded in 2005 and is headquartered in Vancouver, Canada. Address: 1055 West Hastings Street, Vancouver, BC, Canada, V6E 2E9
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service